Navigating prostate cancer control in Nigeria

Chidebe, Runcie C.W.; Orjiakor, Charles T.; Pereira, Ian; Ipiankama, Sampson C; Lounsbury, David W.; Moraes, Fábio Ynoe de

doi:10.1016/s1470-2045(19)30625-4

Cited by 13 publications

(9 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3 In Nigeria, the prevalence of cancer was estimated to be 124,815 cases, resulting in 78,899 deaths. 4 Nigeria's population represents almost one-fifth of Africa's population, and literature shows that the country bears a significant burden of cancer in the continent. 3,5 This can be attributed to low per capita income, the emigration of healthcare professionals, and a deteriorating healthcare system.…”

Section: Introductionmentioning

confidence: 99%

Examining Depression among Breast Cancer Survivors in Nigeria: A Scoping Review

Eseadi,

Amedu

2024

Arch Breast Cancer

View full text Add to dashboard Cite

Background: Depression is one of the major mental health problems that hinder recovery of breast cancer patients. Comorbidity of depressive disorder and breast cancer is a complicated medical condition globally. This study examined depression among breast cancer survivors in Nigeria. Methods: This study used a scoping review approach to explore four databases, which include Google Scholar, PubMed, Medline and Scopus. The search produced 50 records using formulated search terms formulated which are relevant to the topics. Of the 50 records selected, 42 articles that did not meet eligible requirements were removed, and 8 records were included. Results: this study revealed that depression is one of the psychological problems that patients with breast cancer experience in Nigeria. In addition, this review revealed that psychological interventions such as cognitive behavioural therapy (CBT) and pilot cognitive restructuring are effective in reducing the depressive symptoms among breast cancer patients in Nigeria. Conclusion: Based on the published peer reviewed articles, depression is major mental health problem among breast cancer patients in Nigeria, and CBT and psychoeducation have been found to be effective treating depression symptoms in Nigeria. However, more studies are needed in the northern parts of the country since most of the review studies were done in the southern parts of the country.

show abstract

Section: Introductionmentioning

confidence: 99%

Examining Depression among Breast Cancer Survivors in Nigeria: A Scoping Review

Eseadi,

Amedu

2024

Arch Breast Cancer

View full text Add to dashboard Cite

show abstract

“…9 Close to 31% of the population in 2012 were youths aged 15–35 years. 10 In Nigeria, high mortality from PCa persists with approximately 80% of Nigerian patients being incurable at diagnosis 11 . Contributory factors to this include inadequate population awareness, poor health-seeking behaviour, low levels of literacy and empowerment in addition to a poor health system leading to low uptake of screening services, and poor access to treatment.…”

Section: Introductionmentioning

confidence: 99%

“…Awareness of risk factors, need for early detection and better adherence to medical recommendations enable them overcome system barriers to quality cancer. 12 Nonetheless, the situation is different in low-income countries such as Nigeria. 8 The first step of screening for the diagnosis of Nigerian men with PCa is not common and genetic testing is not currently available.…”

Section: Introductionmentioning

confidence: 99%

The Prevalence of Prostate Cancer Among Young Men Below 55 Years of Age in Nigeria

2023

View full text Add to dashboard Cite

Introduction Prostate cancer is the most common cancer in men. It was initially a disease of older men above the age of 55 years. Of recent, there has been reports of increase in the number of young men <55 years with prostate cancer (PCa). The disease in this age group has been reported to be more lethal because of aggressive characteristics and metastatic potential. Different populations have different proportions of young-onset PCa. The aim of this study was to determine the proportion of young men aged <55 years with PCa in Nigeria. Methods Data on the prevalence of young men <55 years with PCa was extracted from the 2022 report of the prevalence of cancer in Nigeria from 2009 to 2016 based on the records of 15 major Cancer Registries in Nigeria. This was a publication of the Nigerian Ministry of Health and represents the most up to date data. Results In 4864 men diagnosed with malignancies before age 55, PCa was the second common, following liver cancer. Out of a total of 4091 cases of PCa in all age groups, 355 were diagnosed in men <55 years representing 8.86%. Furthermore, the proportion of young men with the disease in the Northern part of the country was 11.72%, whereas in the South, it was 7.77%. Conclusions PCa is the second most common cancer in young Nigerian men aged< 55 years preceded by liver cancer. The proportion of young men with PCa was 8.86%. It is therefore important to consider PCa in young men as a different entity and develop appropriate ways to control this disease to ensure survival and good quality of life.

show abstract

“…Reportedly, prostate cancer is currently the most common cancer and the most common cause of cancer death in men in Nigeria. [ 4 6 7 ] Although reported as relatively rare in the past, possibly due to gross under-reporting and absence of screening, more recent reports tend to counter such earlier disposition. [ 8 9 10 ] Despite this shift in incidence status, presentation at late disease stages appears to have persisted with the attendant poor management outcomes and high treatment burden.…”

Section: Introductionmentioning

confidence: 99%

Prostate Cancer Characteristics

Ugwumba

Nnabugwu

2022

Annals of African Medicine

View full text Add to dashboard Cite

Background: Prostate cancer, previously reported as relatively rare in Nigeria, is currently the leading cancer and leading cause of cancer-related death in men. Late presentation appears to persist despite higher incidence rates and instituted awareness programs. This study assesses current prostate cancer indices at presentation to a 3 rd tier referral hospital in South-east Nigeria and compares these indices with reported indices from previous decades. Materials and Methods: Retrospectively, the medical records of men presenting with histologically confirmed prostate cancer from January 2009 to April 2018 were reviewed. Age, spectrum and duration of clinical features, serum total prostate-specific antigen (tPSA), and prostate biopsy specimen Gleason Score (GS) at presentation were retrieved for the analysis using the SPSS software version 21. Obtained mean values and proportions were compared to reports from previous decades for observable shifts. Results: The medical records of 331 men 51–90 years of age (mean: 69.8 ± 8.0 years) were retrieved. Six (1.8%) men (median tPSA = 28.0 ng/ml; range 10.0–121.4 ng/ml) had screening-detected prostate cancer. About 72.0%, 52.0%, and 30.3% of men present with symptoms after 3 months, 6 months, and 12 months, respectively, and about 55.1% had other clinical features of disease progression beyond lower urinary tract symptoms. Symptom duration, serum tPSA (median 31.4 ng/ml; range 4.0–710.0 ng/ml), and % fPSA (median 20.6%; range 57.1%–8.6%) at presentation, as well as prevalent poorly-differentiated tumor (GS ≥7 [4 + 3] 62.2%) are yet to shift from reports from previous decades. Conclusions: Prostate cancer indices at presentation in South-eastern Nigeria, a resource-poor community in sub-Saharan Africa are yet to positively shift despite efforts at prostate cancer awareness.

show abstract

Navigating prostate cancer control in Nigeria

Cited by 13 publications

References 0 publications

Examining Depression among Breast Cancer Survivors in Nigeria: A Scoping Review

Examining Depression among Breast Cancer Survivors in Nigeria: A Scoping Review

The Prevalence of Prostate Cancer Among Young Men Below 55 Years of Age in Nigeria

Prostate Cancer Characteristics

Contact Info

Product

Resources

About